CCDR: Volume 46-10-October 2020: Laboratory Biosafety

The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.

Données et ressources

Info additionnelle

Champ Valeur
Dernière modification avril 17, 2026, 20:25 (TU)
Créé le avril 17, 2026, 20:25 (TU)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_modified 2020-10-22 00:00:00
open_canada_date_published 2020-10-01 00:00:00
open_canada_keywords {"fr": ["liste de contrôle", "COVID-19", "Ebola", "maladie infectieuse émergente", "gestion des urgences", "agents pathogènes à haute conséquence", "maladie infectieuse", "intervention des laboratoires", "préparation aux épidémies", "interventions contre les épidémies", "laboratoire de santé publique", "SRAS", "SRAS-CoV-2", "Zika", "COVID-19", "Canada", "dépistage aux points de service", "Comité consultatif national de l’immunisation", "CCNI", "mammifères", "culture cellulaire", "MDCK", "vaccin antigrippal", "spectrométrie de masse MALDI-TOF", "pathogènes bactériens", "diagnostics de laboratoire de microbiologie clinique", "cote de sécurité élevée", "immunisation", "méningococcie", "méningococcie invasive", "sérotype W", "COVID-19", "Canada", "mortalité", "épidémiologie", "taux de létalité", "myélite flasque aiguë", "paralysie flasque aiguë", "entérovirus", "maladie infectieuse", "surveillance", "maladie de Lyme", "surveillance sentinelle", "tique Ixodes", "Borrelia", "Canadian Lyme Disease Research Network (CLyDRN)", "fièvre récurrente à tiques", "Borrelia hermsii", "Ornithodoros", "réaction de Jarisch-Herxheimer", "surveillance de la maladie", "immunisation", "programmes scolaires", "santé publique", "douleur", "peur", "guide de pratiques cliniques", "hésitation vaccinale"], "en": ["checklist", "COVID-19", "Ebola", "emerging infectious disease", "emergency management", "high consequence pathogens", "infectious disease", "laboratory response", "outbreak preparedness", "outbreak response", "public health laboratory", "SARS", "SARS-CoV-2", "Zika", "COVID-19", "Canada", "point-of-care testing", "National Advisory Committee on Immunization", "NACI", "mammalian", "cell culture", "MDCK", "influenza vaccine", "MALDI-TOF mass spectrometry", "bacterial pathogens", "clinical microbiology laboratory diagnostics", "security-sensitive", "immunization", "meningococcal disease", "IMD", "serotype W", "COVID-19", "Canada", "mortality", "epidemiology", "case fatality rate", "acute flaccid myelitis", "acute flaccid paralysis", "enterovirus", "infectious disease", "surveillance", "Lyme disease", "sentinel surveillance", "Ixodes tick", "Borrelia", "Canadian Lyme Disease Research Network (CLyDRN)", "tick-borne relapsing fever", "Borrelia hermsii", "Ornithodoros", "Jarisch-Herxheimer reaction", "disease surveillance", "immunization", "school programs", "public health", "pain", "fear", "clinical practice guideline", "vaccine hesitancy"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr RMTC : Volume 46–10- octobre 2020 : Biosécurité en Laboratoire
update_frequency unknown